The Oligofastx consortium is composed of the following companies.
  • Sylentis S.A.
  • Aptatargets S.L.
  • Aptus Biotech S.L.
  • Arthex Biotech S.L.
  • Biotechnology Development for Indutry in Pharmaceuticals S.L.
  • Nanovex Biotechnologies S.L.
  • Nostrum Biodiscovery S.L
This consortium has no legal status. The Oligofastx Consortium and, therefore, its partner companies make available to the user the information on the website (hereinafter “the Site”) which is subject to a disclaimer, a copyright notice and rules relating to the protection of personal data.
The Oligofastx consortium makes no warranties or representations of any kind as to the accuracy, currency or completeness of the content. Neither the Oligofastx consortium nor any party involved in creating, producing, or delivering this document shall be liable for any damages, including, without limitation, direct, incidental, consequential, indirect, or punitive damages, arising out of access, use, or inability to use. this document, or any error or omission in the content of this document.
No graphic material or element identifying the corporate image of the Oligofastx Consortium or of the companies and entities included in the Site may be used without express consent. This material may not be used for commercial purposes. Re-use of content is not permitted except for private, academic or educational use.